These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 9221228)

  • 1. [Rheumatoid arthritis shortens life].
    Myllykangas-Luosujärvi R; Aho K; Kautiainen H; Isomäki H
    Duodecim; 1995; 111(13):1209-15. PubMed ID: 9221228
    [No Abstract]   [Full Text] [Related]  

  • 2. Death attributed to antirheumatic medication in a nationwide series of 1666 patients with rheumatoid arthritis who have died.
    Myllykangas-Luosujärvi R; Aho K; Isomäki H
    J Rheumatol; 1995 Dec; 22(12):2214-7. PubMed ID: 8835551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Excess mortality in rheumatoid arthritis--is it the disease or the drugs?
    Symmons D
    J Rheumatol; 1995 Dec; 22(12):2200-2. PubMed ID: 8835548
    [No Abstract]   [Full Text] [Related]  

  • 4. Recent improvements in survival in patients with rheumatoid arthritis: better outcomes or different study designs?
    Ward MM
    Arthritis Rheum; 2001 Jun; 44(6):1467-9. PubMed ID: 11407710
    [No Abstract]   [Full Text] [Related]  

  • 5. Malignancies in patients with rheumatoid arthritis.
    Koivuniemi R; Paimela L; Suomalainen R; Leirisalo-Repo M
    Scand J Rheumatol; 2011 Mar; 40(2):154-5. PubMed ID: 20858144
    [No Abstract]   [Full Text] [Related]  

  • 6. Patient, disease, and therapy-related factors that influence discontinuation of disease-modifying antirheumatic drugs: a population-based incidence cohort of patients with rheumatoid arthritis.
    Maradit-Kremers H; Nicola PJ; Crowson CS; O'Fallon WM; Gabriel SE
    J Rheumatol; 2006 Feb; 33(2):248-55. PubMed ID: 16358365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Premature mortality in patients with rheumatoid arthritis: evolving concepts.
    Pincus T; Sokka T; Wolfe F
    Arthritis Rheum; 2001 Jun; 44(6):1234-6. PubMed ID: 11407680
    [No Abstract]   [Full Text] [Related]  

  • 8. Prevalence of dermatophytosis in patients with rheumatoid arthritis.
    Bicer A; Tursen U; Cimen OB; Kaya TI; Ozisik S; Ikizoglu G; Erdogan C
    Rheumatol Int; 2003 Jan; 23(1):37-40. PubMed ID: 12548440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mortality in rheumatoid arthritis. Increased in the early course of disease, in ischaemic heart disease and in pulmonary fibrosis.
    Young A; Koduri G; Batley M; Kulinskaya E; Gough A; Norton S; Dixey J;
    Rheumatology (Oxford); 2007 Feb; 46(2):350-7. PubMed ID: 16908509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of rofecoxib and naproxen on life expectancy among patients with rheumatoid arthritis: a decision analysis.
    Choi HK; Seeger JD; Kuntz KM
    Am J Med; 2004 May; 116(9):621-9. PubMed ID: 15093759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. What kills patients with rheumatoid arthritis?
    Kelly C; Hamilton J
    Rheumatology (Oxford); 2007 Feb; 46(2):183-4. PubMed ID: 17003170
    [No Abstract]   [Full Text] [Related]  

  • 12. Mortality in patients with rheumatoid arthritis treated with low-dose oral glucocorticoids. A population-based cohort study.
    Sihvonen S; Korpela M; Mustonen J; Huhtala H; Karstila K; Pasternack A
    J Rheumatol; 2006 Sep; 33(9):1740-6. PubMed ID: 16881099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sparing of age-related macular degeneration in rheumatoid arthritis.
    Gaynes BI
    Neurobiol Aging; 2006 Oct; 27(10):1531-2; discussion 1533-4. PubMed ID: 16310288
    [No Abstract]   [Full Text] [Related]  

  • 14. "5D" Outcome in 52 patients with rheumatoid arthritis surviving 20 years after initial disease modifying antirheumatic drug therapy.
    Capell H; McCarey D; Madhok R; Hampson R
    J Rheumatol; 2002 Oct; 29(10):2099-105. PubMed ID: 12375318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Co-morbidities increase the risk of serious infections in patients with rheumatoid arthritis treated with TNFalpha inhibitors.
    Davas EM; Alexiou I; Boulbou M; Koutroumpas A; Makaritsis K; Stathakis N; Sakkas LI
    J Infect; 2008 Nov; 57(5):418-20. PubMed ID: 18760485
    [No Abstract]   [Full Text] [Related]  

  • 16. Safety of extended treatment with anakinra in patients with rheumatoid arthritis.
    Fleischmann RM; Tesser J; Schiff MH; Schechtman J; Burmester GR; Bennett R; Modafferi D; Zhou L; Bell D; Appleton B
    Ann Rheum Dis; 2006 Aug; 65(8):1006-12. PubMed ID: 16396977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of nonbiologic disease-modifying antirheumatic drugs and risk of infection in patients with rheumatoid arthritis.
    Lacaille D; Guh DP; Abrahamowicz M; Anis AH; Esdaile JM
    Arthritis Rheum; 2008 Aug; 59(8):1074-81. PubMed ID: 18668604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic strategies in rheumatoid arthritis over a 40-year period.
    Kremers HM; Nicola P; Crowson CS; O'Fallon WM; Gabriel SE
    J Rheumatol; 2004 Dec; 31(12):2366-73. PubMed ID: 15570636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Longterm methotrexate use in rheumatoid arthritis: 12 year followup of 460 patients treated in community practice.
    Wluka A; Buchbinder R; Mylvaganam A; Hall S; Harkness A; Lewis D; Littlejohn GO; Miller MH; Ryan PF
    J Rheumatol; 2000 Aug; 27(8):1864-71. PubMed ID: 10955325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A proposal for developing a large patient population cohort for longterm safety monitoring in rheumatoid arthritis.
    Lipani JA; Strand V; Woodworth T; Furst D; Singh G; Johnson K; Day R; Brooks P
    J Rheumatol; 2000 Apr; 27(4):827-30. PubMed ID: 10782801
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.